MyFinsight
Home
Blog
About
Marketable securities
$195,795K
(13.89%↑ Y/Y)
Cash and cash
equivalents
$24,208K
(-35.63%↓ Y/Y)
Prepaid expenses and
other current assets
$8,716K
(119.60%↑ Y/Y)
Inventory
$4,121K
Accounts receivable, net
$442K
Total current assets
$233,282K
(9.21%↑ Y/Y)
Other assets
$1,791K
(11.80%↑ Y/Y)
Property and equipment,
net
$1,002K
(-14.29%↓ Y/Y)
Operating lease
right-of-use asset
$521K
(-45.67%↓ Y/Y)
Total assets
$236,596K
(8.86%↑ Y/Y)
Total liabilities and
stockholders equity
$236,596K
(8.86%↑ Y/Y)
Total stockholders
equity
$219,262K
(6.25%↑ Y/Y)
Total liabilities
$17,334K
(58.06%↑ Y/Y)
Accumulated deficit
-$300,547K
(-72.19%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$629K
(-1755.26%↓ Y/Y)
Additional paid-in capital
$520,437K
(36.64%↑ Y/Y)
Total current
liabilities
$17,212K
(65.53%↑ Y/Y)
Operating lease
liability, net
$122K
(-78.56%↓ Y/Y)
Common stock, par value
of 0.00001 per...
$1K
(0.00%↑ Y/Y)
Accrued liabilities
$9,779K
(29.63%↑ Y/Y)
Accounts payable
$6,648K
(132.94%↑ Y/Y)
Deferred revenue
$785K
Back
Back
Balance Sheet
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)
source: myfinsight.com